On 2026-08-13, Gossamer Bio, Inc. (GOSS) announced earnings per share of $-16.00 for the fiscal quarter ending 2026-06-30, missing the average analyst estimate of $-8.00.
The next expected annoucement date for quarterly earnings is 2026-11-04, with an average estimated earnings per share of $-5.55 for the fiscal quarter ending 2026-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-08-13 | 2026-06-30 | $-8.00 | $-16.00 |
| 2026-05-15 | 2026-03-31 | $-13.60 | $-16.00 |
| 2026-03-17 | 2025-12-31 | $-16.00 | $-16.80 |
| 2025-11-05 | 2025-09-30 | $-15.20 | $-16.80 |
| 2025-08-05 | 2025-06-30 | $-14.40 | $-13.60 |
| 2025-05-15 | 2025-03-31 | $-14.40 | $-12.80 |
| 2025-03-13 | 2024-12-31 | $-13.60 | $-12.00 |
| 2024-11-07 | 2024-09-30 | $-14.40 | $-11.20 |
| 2024-08-12 | 2024-06-30 | $18.40 | $17.60 |
| 2024-05-07 | 2024-03-31 | $-15.20 | $-15.20 |
| 2024-03-05 | 2023-12-31 | $-16.00 | $-16.80 |
| 2023-11-09 | 2023-09-30 | $-16.00 | $-16.80 |
| 2023-08-08 | 2023-06-30 | $-39.20 | $-36.00 |
| 2023-05-09 | 2023-03-31 | $-44.00 | $-41.60 |
| 2023-03-17 | 2022-12-31 | $-49.60 | $-47.20 |
| 2022-11-03 | 2022-09-30 | $-52.80 | $-52.00 |
| 2022-08-09 | 2022-06-30 | $-53.60 | $-59.20 |
| 2022-05-10 | 2022-03-31 | $-61.60 | $-60.80 |
| 2022-03-03 | 2021-12-31 | $-59.20 | $-59.20 |
| 2021-11-08 | 2021-09-30 | $-62.40 | $-64.00 |
| 2021-08-09 | 2021-06-30 | $-61.60 | $-64.00 |
| 2021-05-06 | 2021-03-31 | $-64.00 | $-62.40 |
| 2021-02-25 | 2020-12-31 | $-64.00 | $-70.40 |
| 2020-11-10 | 2020-09-30 | $-68.80 | $-64.00 |
| 2020-08-11 | 2020-06-30 | $-67.20 | $-80.00 |
| 2020-05-12 | 2020-03-31 | $-64.00 | $-69.60 |
| 2020-03-24 | 2019-12-31 | $-64.00 | $-71.20 |
| 2019-11-12 | 2019-09-30 | $-56.80 | $-64.00 |
| 2019-08-08 | 2019-06-30 | $-44.80 | $-59.20 |
| 2019-05-14 | 2019-03-31 | $-50.40 | $-72.00 |